Skip to main content
    O

    Oscar Health Inc (OSCR)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $29.84
    -1.49 (-4.74%)

    Market Cap: $9.65B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Oscar Health Inc (OSCR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Oscar Health (OSCR) has a market cap of $9.65B and an enterprise value of $5.61B. Its share count is up 19.31% from a year earlier. Revenue grew 54.77% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 41.82% below the market cap, as cash exceeds debt.

    Market Cap$9.65B
    Enterprise Value$5.61B
    Latest price (Nov 17, 2026)$29.84

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.36% in the quarter ended Sep 30, 2026 and grew 12.80% a year over 2 years.

    Shares Outstanding309.34M
    Shares Change (YoY)+19.31%
    Shares Change (QoQ)+2.36%
    Share Count Growth (2Y CAGR)+12.80%

    Valuation Ratios

    Sales and book value multiples are 0.5x and 4.2x.

    P/E Ratio12.3x
    Forward P/E14.1x
    P/S Ratio0.5x
    Forward P/S0.5x
    P/B Ratio4.2x
    P/FCF Ratio2.2x
    P/OCF Ratio2.3x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.6x EBITDA and 1.3x free cash flow.

    EV / Earnings6.6x
    EV / Sales0.3x
    EV / EBITDA5.6x
    EV / EBIT6.1x
    EV / FCF1.3x

    Price Statistics

    The stock is up 115.02% over 52 weeks and trades 6.52% below its 50-day average.

    Beta (1Y)1.38
    52-Week Change+115.02%
    1-Month Change-8.28%
    3-Month Change-7.60%
    6-Month Change+21.72%
    5-Year Change+75.75%
    Total Return (1Y)+115.02%
    Total Return (3Y CAGR)+57.68%
    Total Return (5Y CAGR)+22.93%
    Return vs SPY (1Y)+91.33%
    Max Drawdown (1Y)-40.25%
    Max Drawdown (3Y)-53.39%
    Sharpe Ratio (1Y)1.11
    Correlation with SPY (1Y)0.30
    50-Day Average$31.92
    200-Day Average$24.60
    52-Week Range$10.69 to $38.50
    RSI (14 Days)42.5
    Average Volume (20 Days)5.44M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.14x current liabilities, and total debt is 0.19x shareholder equity.

    Current Ratio1.14x
    Quick Ratio1.14x
    Debt / Equity0.19x
    Debt / EBITDA0.47x
    Debt / FCF0.10x
    Interest Coverage66.92x

    Returns and Efficiency

    Return on invested capital is 32.72% over the last 12 months, against a 5-year average of -29.81%.

    Return on Equity (ROE)38.50%
    Return on Assets (ROA)8.55%
    Return on Invested Capital (ROIC)32.72%
    Return on Capital Employed (ROCE)33.91%
    ROE (5Y Average)-37.21%
    ROA (5Y Average)-8.93%
    ROIC (5Y Average)-29.81%
    Asset Turnover2.22x
    Receivables Turnover51.14x

    Taxes

    Income tax took 5.39% of pretax income over the last 12 months.

    Income Tax (TTM)$48.76M
    Effective Tax Rate5.39%

    Scores

    OSCR has an Altman Z-Score of 2.59, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score2.59
    Altman Z ZoneGrey
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $17.47B over the last 12 months.

    Revenue$17.47B
    Revenue Growth (YoY)+54.77%
    Gross Profit$13.61B
    Operating Income$936.99M
    Pretax Income$904.48M
    Net Income$855.72M
    EBIT$918.21M
    Reported EPS (TTM)$2.42

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 22.18% of the $10.01B in total assets.

    Cash and Equivalents$4.47B
    Total Debt$432.41M
    Net Cash$4.03B
    Net Cash Per Share$13.04
    Working Capital$1.01B
    Shareholder Equity$2.22B
    Book Value Per Share$7.19
    Total Assets$10.01B
    Total Liabilities$7.78B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $40.93M of capital spending, operating cash flow left $4.14B of free cash flow.

    Operating Cash Flow$4.18B
    Capital Expenditures$40.93M
    Free Cash Flow$4.14B
    FCF Per Share$15.15
    Depreciation and Amortization$52.98M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.36%, against a 5-year average of -10.26%.

    Gross Margin77.92%
    Operating Margin5.36%
    Pretax Margin5.18%
    Net Margin4.90%
    EBIT Margin5.26%
    FCF Margin23.70%
    Gross Margin (5Y Average)65.78%
    Operating Margin (5Y Average)-10.26%
    Net Margin (5Y Average)-10.91%

    Growth

    Revenue grew 43.45% a year over 3 years.

    Revenue Growth (3Y CAGR)+43.45%
    Revenue Growth (5Y CAGR)+90.80%
    FCF Growth (3Y CAGR)+44.43%
    FCF Growth (5Y CAGR)+38.37%
    Book Value Per Share Growth (2Y CAGR)-1.26%
    Tangible Book Per Share Growth (2Y CAGR)-1.26%

    Revenue and profit by year

    Dividends and Yields

    OSCR does not pay a dividend. Its free cash flow yield is 44.86%.

    Earnings Yield8.13%
    FCF Yield44.86%
    Shareholder Yield0.00%

    Peer Position

    Against 12 similar companies, OSCR has the 10th highest P/E and the 7th highest P/S.

    P/E Ratio12.3x vs 22.1x median
    P/S Ratio0.5x vs 0.5x median
    ROIC32.72% vs 8.35% median
    Revenue Growth (Trailing 4 Quarters, YoY)+54.77% vs +7.39% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 34.27% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+34.27%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OSCR

    What is OSCR's market cap?

    Oscar Health has a market cap of $9.65B. Its enterprise value, which adds debt and subtracts cash, is $5.61B.

    What is OSCR's P/E ratio?

    Oscar Health has a trailing P/E ratio of 12.3x and a forward P/E of 14.1x.

    How many shares of OSCR are outstanding?

    Oscar Health has 309.34M shares outstanding. The count is up 19.31% from a year earlier.

    Does OSCR pay a dividend?

    No. Oscar Health does not pay a dividend.

    How much debt does OSCR have?

    Oscar Health has $432.41M of total debt and $4.47B of cash and equivalents, a net cash position of $4.03B.